Holen Sie sich die Stockscreener-App
3.74
10.74%
-0.45
Handel nachbörslich:
3.69
-0.05
-1.34%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SAVA?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$4.19
Offen:
$4.25
24-Stunden-Volumen:
4.06M
Relative Volume:
1.89
Marktkapitalisierung:
$180.67M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-97.22M
KGV:
-2.7101
EPS:
-1.38
Netto-Cashflow:
$-82.44M
1W Leistung:
+3.03%
1M Leistung:
+78.10%
6M Leistung:
+214.29%
1J Leistung:
-84.96%
1-Tages-Spanne:
$3.71
$4.28
1-Wochen-Bereich:
$3.39
$4.28
52-Wochen-Spanne:
$1.15
$33.98
Cassava Sciences Inc Stock (SAVA) Company Profile
Firmenname
Cassava Sciences Inc
Sektor
Branche
Telefon
512-501-2444
Adresse
6801 N CAPITAL OF TEXAS HIGHWAY, AUSTIN, TX
Vergleichen Sie SAVA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SAVA
Cassava Sciences Inc
|
3.74 | 202.41M | 0 | -97.22M | -82.44M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Cassava Sciences Inc Stock (SAVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-26 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-10-08 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2024-07-01 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2022-11-16 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2021-07-15 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2021-07-07 | Bestätigt | Maxim Group | Buy |
| 2021-04-27 | Eingeleitet | B. Riley Securities | Buy |
| 2021-02-16 | Bestätigt | H.C. Wainwright | Buy |
| 2020-10-23 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-09-23 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-05-18 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2020-05-15 | Herabstufung | Maxim Group | Buy → Hold |
| 2020-01-10 | Bestätigt | Maxim Group | Buy |
Alle ansehen
Cassava Sciences Inc Aktie (SAVA) Neueste Nachrichten
What data driven models say about Cassava Sciences Inc.’s futureQuarterly Earnings Summary & Real-Time Volume Surge Alerts - newser.com
What indicators show strength in Cassava Sciences Inc.Market Performance Summary & Verified Momentum Stock Alerts - newser.com
Understanding Cassava Sciences Inc. Equity Warrant’s price movementJuly 2025 Rallies & Target Return Focused Stock Picks - newser.com
Pattern recognition hints at Cassava Sciences Inc. upsideWeekly Gains Summary & Weekly Watchlist for Consistent Profits - newser.com
Will Cassava Sciences Inc. (PX91) stock beat growth indexes2025 EndofYear Setup & Safe Swing Trade Setups - newser.com
Can Cassava Sciences Inc. Equity Warrant hit a new high this monthQuarterly Portfolio Report & Weekly Chart Analysis and Guides - newser.com
Visual trend scoring systems applied to Cassava Sciences Inc.Share Buyback & Step-by-Step Trade Execution Guides - newser.com
Cassava Sciences Inc. stock outlook for YEARWeekly Trade Analysis & Consistent Income Trade Ideas - newser.com
Should you hold or exit Cassava Sciences Inc. Equity Warrant nowJuly 2025 WrapUp & AI Enhanced Trading Alerts - newser.com
Is Cassava Sciences Inc. (PX91) stock a buy during volatile marketsJuly 2025 Trends & Weekly Return Optimization Alerts - newser.com
How hedge fund analytics apply to Cassava Sciences Inc. Equity Warrant stock2025 Technical Overview & Accurate Entry and Exit Point Alerts - newser.com
Chart based exit strategy for Cassava Sciences Inc.Earnings Miss & Real-Time Volume Analysis Alerts - newser.com
Risk vs reward if holding onto Cassava Sciences Inc. Equity WarrantPortfolio Update Summary & Free Weekly Watchlist of Top Performers - newser.com
Can Cassava Sciences Inc. Equity Warrant recover in the next quarterWeekly Trend Report & Smart Swing Trading Alerts - newser.com
Using RSI to spot recovery in Cassava Sciences Inc. Equity Warrant2025 Price Momentum & Community Verified Trade Alerts - newser.com
Can Cassava Sciences Inc. Equity Warrant stock attract ESG capital inflowsJuly 2025 Short Interest & Weekly Chart Analysis and Guides - newser.com
Cassava Sciences Inc. Equity Warrant stock trend outlook and recovery pathInsider Selling & Weekly Top Gainers Trade List - newser.com
LUCID CAPITAL MARKETS Initiates Coverage of Cassava Sciences (SAVA) with Buy Recommendation - Nasdaq
Cassava Sciences (SAVA): Lucid Capital Markets Initiates Coverage with Buy Rating | SAVA Stock News - GuruFocus
Lucid Capital Upgrades Cassava Sciences(SAVA.US) to Buy Rating, Raises Target Price to $8 - 富途牛牛
How to build a dashboard for Cassava Sciences Inc. Equity Warrant stockTrade Performance Summary & Growth Focused Stock Pick Reports - newser.com
Will Cassava Sciences Inc. (PX91) stock benefit from mergers2025 Market Sentiment & Free AI Powered Buy and Sell Recommendations - newser.com
Will Cassava Sciences Inc. stock gain from lower inflationGap Up & Weekly Chart Analysis and Trade Guides - newser.com
Is Cassava Sciences Inc. (PX91) stock a safe buy pre earningsMarket Movement Recap & Smart Investment Allocation Tips - newser.com
Can Cassava Sciences Inc. Equity Warrant stock continue upward trendTrade Risk Report & Weekly Sector Rotation Insights - newser.com
Cassava Sciences Inc. Equity Warrant stock daily chart insightsRecession Risk & Real-Time Market Trend Scan - newser.com
Is Cassava Sciences Inc. Equity Warrant meeting your algorithmic filter criteria2025 Geopolitical Influence & Fast Entry Momentum Trade Alerts - newser.com
Cassava Sciences Inc. Equity Warrant stock retracement – recovery analysisExit Point & Low Drawdown Trading Strategies - newser.com
FRST Stock Analysis and ForecastFederal Reserve Announcements & Free Long-Term Investment Planning - earlytimes.in
Is Cassava Sciences Inc a good long term investmentMACD Trading Signals & Investment Timing Techniques - earlytimes.in
Best data tools to analyze Cassava Sciences Inc. Equity Warrant stock2025 Trading Recap & Growth Oriented Trade Recommendations - newser.com
Regression analysis insights on Cassava Sciences Inc. performanceJuly 2025 Spike Watch & Low Risk Profit Maximizing Plans - newser.com
Measuring Cassava Sciences Inc.’s beta against major indices2025 Risk Factors & AI Powered Market Entry Strategies - newser.com
Multi factor analysis applied to Cassava Sciences Inc. Equity Warrant2025 Valuation Update & Stepwise Entry and Exit Trade Signals - newser.com
Insider Buying: Robert Cook Acquires Shares of Cassava Sciences Inc (SAVA) - GuruFocus
Will Cassava Sciences Inc. stock outperform Dow Jones indexJuly 2025 Action & High Accuracy Swing Entry Alerts - newser.com
Finanzdaten der Cassava Sciences Inc-Aktie (SAVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cassava Sciences Inc-Aktie (SAVA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Barry Richard | President & CEO |
Sep 22 '25 |
Buy |
2.28 |
7,172 |
16,352 |
714,675 |
| Barry Richard | President & CEO |
Sep 18 '25 |
Buy |
2.24 |
190,633 |
426,424 |
660,195 |
| Barry Richard | President & CEO |
Sep 19 '25 |
Buy |
2.29 |
47,308 |
108,319 |
707,503 |
| Kupiec James William | Chief Medical Officer |
Nov 29 '24 |
Sale |
3.87 |
4,000 |
15,480 |
0 |
| Schoen Eric | Chief Financial Officer |
Nov 29 '24 |
Option Exercise |
1.18 |
50,000 |
59,000 |
71,300 |
| Schoen Eric | Chief Financial Officer |
Nov 29 '24 |
Sale |
3.86 |
59,800 |
230,828 |
11,500 |
| Schoen Eric | Chief Financial Officer |
Nov 29 '24 |
Sale |
3.82 |
2,000 |
7,640 |
0 |
5.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):